Ayush ministry allows research on Ayush medicines to curb Covid-19 spread

PSM News /

Mumbai, July 22, 2021:

 

The States/Union Territories (UTs) licensing authorities/Drug Controllers have been directed by the Union Ayush Ministry to allow the licensed manufactures for Ayush-64 under their jurisdiction to include new indication of Ayush-64 for repurposing as an intervention for the management of asymptomatic, mild to moderate Covid-19 in addition to existing indications.

 

Further, States/UTs Licensing Authorities have been requested to expedite the process of the licensing/ approval of application for the manufacturing of Ayush-64.

 

Meanwhile, the study conducted by the Ayush in collaboration with the ministry of health and family welfare, ministry of science and technology (CSIR & DBT), Department of Science and Technology and reputed scientific organisations and hospitals states that Ayush medicines are useful in asymptomatic, mild and moderate Covid-19 infection as standalone and as an adjunct to standard care.

 

In order to reduce the effects of Covid-19, the Union Ministry of Ayush has formed an Inter-disciplinary Ayush Research & Development Task Force chaired by Prof Bhushan Patwardhan having representation from scientists of Indian Council of Medical Research (ICMR), Department of Biotechnology (DBT), Council of Scientific & Industrial Research (CSIR), All India Institute of Medical Sciences (AIIMS) and Ayush Institutions.

 

Also, the Interdisciplinary Ayush Research and Development Task Force has formulated and designed clinical research protocols for prophylactic studies and add-on interventions in Covid-19 positive cases through thorough review and consultative process of experts of high repute from different organizations across the country for studying four different interventions viz. Ashwagandha, Yashtimadhu, Guduchi + Pippali and a poly herbal formulation (Ayush-64).

 

Ayush ministry has also launched interdisciplinary studies involving Ayush interventions for Covid-19 based on recommendations of the task force. Under various research organizations and National Institutes under Ministry of Ayush, 126 research studies at 152 centres in the country have been initiated on Ayush interventions. Pharmabiz